Dr. Ali Nsair, MD

Dr. Nsair practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Nsair's NPI, 1366739880, was assigned on July 5, 2011. Dr. Nsair graduated from University of Alberta in 2002. Dr. Nsair holds California license A108268.

Dr. Nsair's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Nsair's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Nsair is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Nsair to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nsair practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Nsair's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Nsair is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dr. Nsair is licensed in California.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, chronic hypertension, circulation problems and coronary artery disease among the conditions Dr. Nsair treats.

CMS data shows 442 Medicare services from Dr. Nsair across 6 procedure codes in 2024, for 176 Medicare patients. Medicare paid $53,458 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 176 Medicare patients who saw Dr. Nsair in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have heart failure, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nsair's median patient age at 58, with 35% women.

In 2024, Dr. Nsair wrote 985 Medicare Part D claims for 96 patients. 64% of them were for generic drugs. CMS names the drug for 818 of them, across 24 drugs with 11 or more claims each, at $475,409 in total drug cost. In 2023, CMS named 784 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Nsair for performance year 2024, reported as part of a group. Dr. Nsair accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nsair as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Nsair. Dr. Nsair's most frequent co-authors are Abbas Ardehali, MD, Reshma M. Biniwale, MD and Ronald W. Busuttil, MD.

CMS Open Payments shows 274 general payments to Dr. Nsair from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Novartis Pharmaceuticals Corporation paid the most, $65,455.

Dr. Nsair graduated from University of Alberta in 2002.

Dr. Nsair is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.